| Name | Cvs Pharmacy #06206 |
|---|---|
| Organization Name | Kentucky Cvs Pharmacy Llc |
| Location | 5121 Antle Dr, Louisville, Kentucky 40229 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (502) 966-2742 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
CTI BioPharma Corp. today announced data showing treatment with pacritinib, an investigational oral multikinase inhibitor in Phase 3 clinical development, preferentially killed acute myeloid leukemia (AML) cells with FLT3 mutations, overcame stromal protection and suppressed leukemic outgrowth from stroma adherent AML cells in both medium-term (7-14 days) and long-term (5-6 weeks) assays.
United Therapeutics Corporation today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration.
Scientists believe they may have found a preventative therapy for type 1 diabetes, by making the body's killer immune cells tolerate the insulin-producing cells they would normally attack and destroy, prior to disease onset.
Medizone International, Inc. Chairman of the Board and Chief Executive Officer, Edwin Marshall, today outlined the company's plans moving forward for its hospital sterilization system, AsepticSure(TM).
Patients with cancer that has spread to their bones are often treated with radiation therapy to reduce pain. But if that treatment doesn't work, or can't be used again, a second, effective option now exists.
› Verified 3 days ago
| NPI Number | 1477656114 |
| Organization Name | KENTUCKY CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY # 06206 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5121 Antle Dr, Louisville, KY 40229 |
| Phone Number | 502-966-2742 |
News Archive
CTI BioPharma Corp. today announced data showing treatment with pacritinib, an investigational oral multikinase inhibitor in Phase 3 clinical development, preferentially killed acute myeloid leukemia (AML) cells with FLT3 mutations, overcame stromal protection and suppressed leukemic outgrowth from stroma adherent AML cells in both medium-term (7-14 days) and long-term (5-6 weeks) assays.
United Therapeutics Corporation today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration.
Scientists believe they may have found a preventative therapy for type 1 diabetes, by making the body's killer immune cells tolerate the insulin-producing cells they would normally attack and destroy, prior to disease onset.
Medizone International, Inc. Chairman of the Board and Chief Executive Officer, Edwin Marshall, today outlined the company's plans moving forward for its hospital sterilization system, AsepticSure(TM).
Patients with cancer that has spread to their bones are often treated with radiation therapy to reduce pain. But if that treatment doesn't work, or can't be used again, a second, effective option now exists.
› Verified 3 days ago
News Archive
CTI BioPharma Corp. today announced data showing treatment with pacritinib, an investigational oral multikinase inhibitor in Phase 3 clinical development, preferentially killed acute myeloid leukemia (AML) cells with FLT3 mutations, overcame stromal protection and suppressed leukemic outgrowth from stroma adherent AML cells in both medium-term (7-14 days) and long-term (5-6 weeks) assays.
United Therapeutics Corporation today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration.
Scientists believe they may have found a preventative therapy for type 1 diabetes, by making the body's killer immune cells tolerate the insulin-producing cells they would normally attack and destroy, prior to disease onset.
Medizone International, Inc. Chairman of the Board and Chief Executive Officer, Edwin Marshall, today outlined the company's plans moving forward for its hospital sterilization system, AsepticSure(TM).
Patients with cancer that has spread to their bones are often treated with radiation therapy to reduce pain. But if that treatment doesn't work, or can't be used again, a second, effective option now exists.
› Verified 3 days ago
Korrect Optical Type: Medicare Supplier Location: 4036 Dutchmans Ln, Louisville, Kentucky 40207 Phone: (502) 895-2020 | |
Korrect Optical Type: Medicare Supplier Location: 4917 Dixie Hwy, Louisville, Kentucky 40216 Phone: (502) 447-2020 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10500 Bluegrass Pkwy, Louisville, Kentucky 40299 Phone: (502) 499-9099 | |
Atlasmedart Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 310 E Broadway, Louisville, Kentucky 40202 Phone: (502) 630-1995 | |
Audubon Pharmacy Type: Pharmacy Location: 3503 Poplar Level Road, Louisville, Kentucky 40213 Phone: (502) 371-1002 |